EcoDrugPlus

Macrophage-Stimulating Protein Receptor

Ensembl ID : ENSFHEG00000020522
Gene Symbol: LOC105933677
2 Cross references
196 Possible Orthologues:

Mast Cell Protease 1a

Ensembl ID : ENSFHEG00000021499
Gene Symbol: LOC105932434
2 Cross references
1011 Possible Orthologues:

Mast Cell Protease 1a-Like

Ensembl ID : ENSFHEG00000021490
Gene Symbol: LOC105932435
2 Cross references
1011 Possible Orthologues:

Mast/stem Cell Growth Factor Receptor Kita-Like

Ensembl ID : ENSFHEG00000003926
Gene Symbol: LOC105916745
3 Cross references
207 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSFHEG00000005077
Gene Symbol: MMP1
4 Cross references
303 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSFHEG00000019517
Gene Symbol: MMP14
3 Cross references
199 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSFHEG00000004101
Gene Symbol: MMP2
3 Cross references
210 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSFHEG00000004917
Gene Symbol: MMP9
3 Cross references
216 Possible Orthologues:

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSFHEG00000017542
Gene Symbol: LOC105930289
3 Cross references
198 Possible Orthologues:

Matrix Metalloproteinase-20-Like

Ensembl ID : ENSFHEG00000004324
Gene Symbol: LOC105919592
2 Cross references
164 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSFHEG00000012058
Gene Symbol: MTOR
3 Cross references
222 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSFHEG00000021344
Gene Symbol: MC1R
1 Cross references
159 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).